Laserfiche WebLink
<br />) <br /> <br />Determination, without regard to whether the advice was relied upon in making the Adverse <br />Benefit Determination. <br /> <br />) <br /> <br />15.07.07 The appeal shall provide that the Health Professional engaged for purposes of a consultation <br />in Subsection 15.07.05 shall be an individual who is neither an individual who was <br />consulted in connection with the initial Adverse Benefit Determination that is the subject of <br />the appeal, nor the subordinate of any such individual. <br /> <br />15.07.08 In the case of an Urgent Care Claim, there shall be an expedited review process pursuant to <br />which: <br /> <br />a) Request for an expedited appeal of an Adverse Benefit Determination may be snbmitted <br />orally or in writing by the Claimant; and <br /> <br />b) All necessary inforrnation, including AvMed's benefit determination on review, shall be <br />transmitted between Av Med and the Claimant by telephone, facsimile, or other <br />available similarly expeditious methods. <br /> <br />15.08 Manner and content of appeal notification. AvMed shall provide a Claimant with written or <br />electronic notification of AvMed's benefit determination upon review. <br /> <br />15.08.01 In the case of an Adverse Benefit Determination, the notification shall set forth, in a marmer <br />calculated to be understood by the Claimant, all of the following, as appropriate: <br /> <br />a) The specific reasons for the Adverse Benefit Determination. <br /> <br />b) Reference to the specific Plan provisions on which the Adverse Benefit Determination <br />is based. <br /> <br />c) <br /> <br />c) A statement that the Claimant is entitled to receive, upon request, and free of charge, <br />reasonable access to, and copies of any Relevant Documents. <br /> <br />d) A statement describing any voluntary appeal procedures offered by AvMed and the <br />Claimant's right to obtain the information about such procedures and a statement of the <br />Claimant's right to bring an action under ERISA Section 502(a) when applicable. <br /> <br />c) If an internal rule, guideline, protocol, or other similar criterion was relied upon in <br />making the Adverse Benefit Determination, either the specific rule, guideline, protocol, <br />or other similar criterion or a statement that such rule, guideline, protocol, or other <br />similar criterion was relied upon in making the Adverse Benefit Determination and that <br />a copy shall be provided free of charge to the Claimant upon request. <br /> <br />f) If the Adverse Benefit Determination is based on whether the treatment or service is <br />experimental and/or investigational or not Medically Necessary, either an explanation <br />of the scientific or clinical judgment for the determination, applying the terms of the <br />Plan to the Claimant's medical circumstances, or a statement that such explanation shall <br />be provided free of charge upon request. <br /> <br />XVI. MISCELLANEOUS <br /> <br />16.01 Applicability of law. The provisions of this Contract shall be deemed to have been modified by the <br />parties, and shall be interpreted, so as to comply with the laws and regulations of the State of Florida <br />and the United States. <br /> <br />16.02 Assigmnent. This Contract, and all rights and benefits related thereto, may not be assigned by the <br />Subscribing Group or the Mcmbcrs without written consent of AvMed. <br /> <br />47 <br /> <br />A V-CHOICE-2009 <br />MP-5320 (10/09) <br />